Cargando…
New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom
In the UK, the annual cost of treatment and care for people with human immunodeficiency virus (HIV)/acquired immune deficiency virus (AIDS) rose by over 600% from £104 million in 1997 to £762 million in 2010; approximately two-thirds of the £762 million cost of treatment and care in 2010 was for the...
Autores principales: | Gazzard, Brian, Moecklinghoff, Christiane, Hill, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414377/ https://www.ncbi.nlm.nih.gov/pubmed/22888265 http://dx.doi.org/10.2147/CEOR.S12496 |
Ejemplares similares
-
Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom
por: van Halsema, Clare L., et al.
Publicado: (2020) -
Antiretroviral medication adherence for people with HIV/AIDS
por: Supriyatni, Nani, et al.
Publicado: (2023) -
A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV
por: Clay, Patrick G., et al.
Publicado: (2018) -
Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
por: Llibre, Josep M, et al.
Publicado: (2013) -
Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials
por: Nelson, Mark, et al.
Publicado: (2014)